Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
UBS
Harvard Business School
Citi
Dow
Fish and Richardson
Moodys
Deloitte
QuintilesIMS

Generated: June 24, 2018

DrugPatentWatch Database Preview

Teva Parenteral Company Profile

« Back to Dashboard

What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?

TEVA PARENTERAL has forty-seven approved drugs.

There are six tentative approvals on TEVA PARENTERAL drugs.

Summary for Teva Parenteral
US Patents:0
Tradenames:39
Ingredients:37
NDAs:47
Patent Litigation for Teva Parenteral: See patent lawsuits for Teva Parenteral

Drugs and US Patents for Teva Parenteral

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Parenteral AMPHOTERICIN B amphotericin b INJECTABLE;INJECTION 064062-001 Mar 31, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Teva Parenteral BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 064084-001 Jun 1, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Teva Parenteral DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 072999-001 Oct 23, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Teva Parenteral CYTARABINE cytarabine INJECTABLE;INJECTION 016793-003 Dec 21, 1987 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Teva Parenteral

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Parenteral CYTARABINE cytarabine INJECTABLE;INJECTION 016793-001 Approved Prior to Jan 1, 1982 3,444,294 ➤ Try a Free Trial
Teva Parenteral CYTARABINE cytarabine INJECTABLE;INJECTION 016793-002 Approved Prior to Jan 1, 1982 3,444,294 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Citi
Federal Trade Commission
Moodys
Johnson and Johnson
US Department of Justice
Teva
AstraZeneca
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.